𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antifungal prophylaxis in liver transplant recipients: a randomized placebo-controlled study

✍ Scribed by Gianni Biancofiore,Maria L. Bindi,Rubia Baldassarri…

Book ID
113019951
Publisher
Springer
Year
2002
Tongue
English
Weight
89 KB
Volume
15
Category
Article
ISSN
0934-0874

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antifungal prophylaxis in liver transpla
Antifungal prophylaxis in liver transplant recipients
✍ Gregory A. Eschenauer; Simon W. Lam; Peggy L. Carver 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB

Although the overall incidence of fungal infections in liver transplant recipients has declined, these infections still contribute significantly to the morbidity and mortality of patients with risk factors for infection. Although antifungal prophylaxis has been widely studied and practiced, no conse

Erratum: Antifungal prophylaxis in liver
Erratum: Antifungal prophylaxis in liver transplant recipients
✍ Gregory A. Eschenauer; Simon W. Lam; Peggy L. Carver 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

UNOS status 4 (life support in ICU) 146 6.3 (2.4-16.7) George 1997 ( 14 ) Donor CMV þ/recipient -146 4.8 (2.0-11.8) George 1997 ( 14 ) UNOS class I (life support in ICU) 172 3.5 (1.7-7.0) Winston 1999 ( 23 ) Fungal colonization at baseline 172 2.3 (1.2-4.3) Winston 1999 ( 23 ) Pretransplant SCr 3 mg

Prophylactic fluconazole in liver transp
Prophylactic fluconazole in liver transplant recipients: A randomized, double-blind, placebo-controlled trial
✍ Robin Patel 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Background: Among persons who receive solid organ transplants, liver transplant recipients have the highest incidence of invasive fungal infection; however, no antifungal prophylaxis has been proven to be effective. ## Objective : To evaluate the efficacy and safety of prophylactic fluconazole in